Pharma Mar, S.A. (BME: PHM)
Spain
· Delayed Price · Currency is EUR 73.55
-1.00 (-1.34%)
Nov 21, 2024, 2:46 PM CET
Pharma Mar Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 0.62 | 1.14 | 49.36 | 92.86 | 137.26 | -11.38 | Upgrade
|
| Depreciation & Amortization | 5.11 | 4.72 | 4.89 | 4.56 | 4.33 | 4.3 | Upgrade
|
| Other Amortization | 1.03 | 1.03 | 1.01 | 1.03 | 2.88 | 3.73 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.8 | 1.93 | -0.01 | 0.03 | 0.03 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | -1.68 | -1.75 | 1.48 | -0.18 | 0.37 | -0.08 | Upgrade
|
| Stock-Based Compensation | 0.32 | 0.3 | 0.39 | 0.34 | 0.27 | 0.27 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 0.02 | 0.03 | Upgrade
|
| Other Operating Activities | 13.96 | 14.1 | 9.42 | -11.55 | 5.84 | -10.77 | Upgrade
|
| Change in Accounts Receivable | -3.53 | 1.78 | 21.61 | -26.76 | -12.63 | -16.52 | Upgrade
|
| Change in Inventory | -12.87 | -11.54 | -17.21 | 1.4 | -3.03 | -2.42 | Upgrade
|
| Change in Accounts Payable | 15.13 | 1.83 | 1.79 | 7.19 | 4.65 | 5.5 | Upgrade
|
| Change in Other Net Operating Assets | -18.24 | -26.99 | -34.41 | -43.23 | 138.95 | -0.14 | Upgrade
|
| Operating Cash Flow | 1.65 | -13.45 | 38.32 | 25.68 | 278.94 | -24.21 | Upgrade
|
| Operating Cash Flow Growth | - | - | 49.24% | -90.79% | - | - | Upgrade
|
| Capital Expenditures | -19.32 | -15.96 | -8.85 | -7.8 | -3 | -3.96 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.01 | - | - | 0.03 | Upgrade
|
| Divestitures | - | - | - | - | - | 33.39 | Upgrade
|
| Investment in Securities | 1.62 | -27.09 | 19.72 | 26.28 | -116.01 | -0.02 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 2.64 | Upgrade
|
| Investing Cash Flow | -17.7 | -43.05 | 10.88 | 18.47 | -119.01 | 32.07 | Upgrade
|
| Long-Term Debt Issued | - | 6.39 | 1.54 | 5.83 | 0.83 | 4.79 | Upgrade
|
| Total Debt Issued | 16.85 | 6.39 | 1.54 | 5.83 | 0.83 | 4.79 | Upgrade
|
| Long-Term Debt Repaid | - | -7.54 | -10.2 | -15.27 | -32.37 | -18.84 | Upgrade
|
| Total Debt Repaid | -7.79 | -7.54 | -10.2 | -15.27 | -32.37 | -18.84 | Upgrade
|
| Net Debt Issued (Repaid) | 9.07 | -1.15 | -8.66 | -9.44 | -31.54 | -14.05 | Upgrade
|
| Issuance of Common Stock | 2.65 | 18.61 | 57.23 | 33.55 | 30.37 | 8.56 | Upgrade
|
| Repurchase of Common Stock | -16.18 | -37.9 | -50.18 | -40.66 | -63.71 | -7.47 | Upgrade
|
| Common Dividends Paid | -11.42 | -11.69 | -11.76 | -10.87 | -8.82 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.12 | -0.01 | Upgrade
|
| Financing Cash Flow | -15.88 | -32.14 | -13.37 | -27.42 | -73.82 | -12.97 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.79 | -1.16 | 0.64 | 0.4 | -7.54 | - | Upgrade
|
| Net Cash Flow | -35.18 | -89.79 | 36.47 | 17.14 | 78.57 | -5.11 | Upgrade
|
| Free Cash Flow | -17.67 | -29.4 | 29.47 | 17.87 | 275.94 | -28.17 | Upgrade
|
| Free Cash Flow Growth | - | - | 64.87% | -93.52% | - | - | Upgrade
|
| Free Cash Flow Margin | -10.58% | -18.59% | 15.01% | 7.78% | 102.21% | -32.83% | Upgrade
|
| Free Cash Flow Per Share | -1.01 | -1.64 | 1.63 | 0.99 | 15.06 | -1.53 | Upgrade
|
| Cash Interest Paid | 2.43 | 2.42 | 2.38 | 3.37 | 3.12 | 2.32 | Upgrade
|
| Cash Income Tax Paid | - | -16.59 | -2.72 | 7.86 | 9.65 | - | Upgrade
|
| Levered Free Cash Flow | -17.05 | -12.59 | 33.11 | 4.75 | 128.41 | -4.65 | Upgrade
|
| Unlevered Free Cash Flow | -15.54 | -11.08 | 34.6 | 6.86 | 130.36 | -2.22 | Upgrade
|
| Change in Net Working Capital | 0.68 | -1.22 | -10.86 | 49.04 | -27.98 | -4.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.